Lyell Immunopharma
LYEL
Insider trades and stock quote 2024-2026
All insider trades at Lyell Immunopharma
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/17/2026
|
Sell |
Innovative Cellular Therapeutics Holdings Ltd |
Ten Percent Owner |
$13.7 |
$137 |
|
7/16/2026
|
Sell |
Innovative Cellular Therapeutics Holdings Ltd |
Ten Percent Owner |
$13.7 |
$137 |
|
6/10/2026
|
Sell |
Shook, David |
Chief Medical Officer |
$12.6 |
$24,989 |
|
5/11/2026
|
Sell |
Seely, Lynn |
President and CEO |
$18.9 |
$7,337 |
|
5/11/2026
|
Sell |
Hill, Stephen J. |
Chief Operating Officer |
$18.9 |
$1,684 |
|
5/11/2026
|
Sell |
Lee, Gary K. |
Chief Scientific Officer |
$18.9 |
$2,460 |
|
5/11/2026
|
Sell |
Bulis, Veronica Sanchez |
VP, Corporate Controller |
$18.9 |
$4,103 |
|
3/6/2026
|
Buy |
Arch Venture Fund Xiii, L.p. |
Ten Percent Owner |
$25.6 |
$12,499,985 |
|
3/6/2026
|
Buy |
Arch Venture Partners Ix, LLC |
Ten Percent Owner |
$25.6 |
$12,499,985 |
|
2/11/2026
|
Sell |
Seely, Lynn |
President and CEO |
$23.4 |
$174,372 |
|
2/11/2026
|
Sell |
Hill, Stephen J. |
Chief Operating Officer |
$23.4 |
$28,910 |
|
2/11/2026
|
Sell |
Lee, Gary K. |
Chief Scientific Officer |
$23.4 |
$39,085 |
|
2/10/2026
|
Sell |
Seely, Lynn |
President and CEO |
$23.1 |
$10,127 |
|
2/10/2026
|
Sell |
Hill, Stephen J. |
Chief Operating Officer |
$23.1 |
$2,520 |
|
2/10/2026
|
Sell |
Lee, Gary K. |
Chief Scientific Officer |
$23.1 |
$3,399 |
|
2/10/2026
|
Sell |
Bulis, Veronica Sanchez |
VP, Corporate Controller |
$23.1 |
$5,872 |
|
12/30/2025
|
Sell |
Bulis, Veronica Sanchez |
VP, Corporate Controller |
$32.3 |
$30,252 |
|
12/24/2025
|
Sell |
Bulis, Veronica Sanchez |
VP, Corporate Controller |
$38.7 |
$43,929 |
|
11/10/2025
|
Sell |
Seely, Lynn |
President and CEO |
$16.1 |
$6,637 |
|
11/10/2025
|
Sell |
Hill, Stephen J. |
Chief Operating Officer |
$16.1 |
$1,531 |
|
11/10/2025
|
Sell |
Lee, Gary K. |
Chief Scientific Officer |
$16.2 |
$2,230 |
|
11/10/2025
|
Sell |
Bulis, Veronica Sanchez |
VP, Corporate Controller |
$16.1 |
$3,848 |
|
8/21/2025
|
Sell |
Lee, Gary K. |
Chief Scientific Officer |
$10.5 |
$15,320 |
|
8/21/2025
|
Sell |
Newton, Charles W. |
Chief Financial Officer |
$10.5 |
$15,320 |
|
8/21/2025
|
Sell |
Hill, Stephen J. |
Chief Operating Officer |
$10.5 |
$10,586 |
|
8/21/2025
|
Sell |
Seely, Lynn |
President and CEO |
$10.5 |
$76,518 |
|
8/12/2025
|
Sell |
Newton, Charles W. |
Chief Financial Officer |
$10.3 |
$1,406 |
|
8/12/2025
|
Sell |
Lee, Gary K. |
Chief Scientific Officer |
$10.3 |
$1,406 |
|
8/12/2025
|
Sell |
Hill, Stephen J. |
Chief Operating Officer |
$10.3 |
$972 |
|
8/12/2025
|
Sell |
Seely, Lynn |
President and CEO |
$10.3 |
$4,197 |
|
8/11/2025
|
Sell |
Newton, Charles W. |
Chief Financial Officer |
$10.5 |
$1,379 |
|
8/11/2025
|
Sell |
Lee, Gary K. |
Chief Scientific Officer |
$10.5 |
$1,379 |
|
8/11/2025
|
Sell |
Hill, Stephen J. |
Chief Operating Officer |
$10.5 |
$958 |
|
8/11/2025
|
Sell |
Seely, Lynn |
President and CEO |
$10.5 |
$4,116 |
|
3/31/2025
|
Buy |
Brawley, Otis W. |
Director |
$0.6 |
$19,958 |
|
3/21/2025
|
Buy |
Ramachandra, Sumant |
Director |
$0.6 |
$115,220 |
|
3/17/2025
|
Buy |
Newton, Charles W. |
Chief Financial Officer |
$0.6 |
$111,620 |
|
3/14/2025
|
Buy |
Seely, Lynn |
President and CEO |
$0.6 |
$106,190 |
|
3/14/2025
|
Buy |
Klausner, Richard |
Director |
$0.6 |
$94,942 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address